Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01875367
What this trial is testing

Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 166
Testing effectiveness (Phase 2)Ended earlyNCT05590377
What this trial is testing

Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Teva Branded Pharmaceutical Products R&D LLC 15
Testing effectiveness (Phase 2)Study completedNCT02775903
What this trial is testing

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 213
Testing effectiveness (Phase 2)Looking for participantsNCT06116682
What this trial is testing

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Who this might be right for
Lung Non-Small Cell Carcinoma
SWOG Cancer Research Network 88
Post-approval studies (Phase 4)Ended earlyNCT01738724
What this trial is testing

Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin

Who this might be right for
Uterine Leiomyoma
University of Sao Paulo 14
Not applicableStudy completedNCT02449148
What this trial is testing

Nutrition and Energy Restriction for Cancer Prevention

Who this might be right for
ObesityVisceral ObesityWeight Loss+2 more
German Cancer Research Center 150
Early research (Phase 1)Ended earlyNCT03249792
What this trial is testing

Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)

Who this might be right for
Solid TumorLymphoma
Merck Sharp & Dohme LLC 140
Testing effectiveness (Phase 2)Study completedNCT01706666
What this trial is testing

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Mayo Clinic 3
Large-scale testing (Phase 3)UnknownNCT01602939
What this trial is testing

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
Hospital Virgen de la Salud 10
Post-approval studies (Phase 4)UnknownNCT06498037
What this trial is testing

Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.

Who this might be right for
Cancer Pain
Erasmus Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT02654990
What this trial is testing

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
pharmaand GmbH 248
Not applicableStudy completedNCT02494115
What this trial is testing

Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Phase Cancer Patients

Who this might be right for
Lymphedema
Centre Hospitalier Universitaire de Nice 24
Large-scale testing (Phase 3)Study completedNCT04024462
What this trial is testing

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Hoffmann-La Roche 200
Large-scale testing (Phase 3)Study completedNCT01724021
What this trial is testing

Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

Who this might be right for
Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma
Hoffmann-La Roche 743
Early research (Phase 1)Ended earlyNCT04348916
What this trial is testing

Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors

Who this might be right for
CancerMelanomaSolid Tumor+7 more
Oncorus, Inc. 66
Not applicableStudy completedNCT02611739
What this trial is testing

Medi-Port Pilot Randomized Controlled Trial

Who this might be right for
Actively Undergoing Cancer Treatment4-9 Years of AgeAt Least 1 Month From Diagnosis+2 more
The Hospital for Sick Children 40
Testing effectiveness (Phase 2)Study completedNCT04346888
What this trial is testing

Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 30
Not applicableStudy completedNCT03471741
What this trial is testing

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Who this might be right for
Breast CancerRadiation Toxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Large-scale testing (Phase 3)Study completedNCT01649856
What this trial is testing

Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)Looking for participantsNCT06057675
What this trial is testing

Tranexamic Acid in Nasal Mohs Reconstruction

Who this might be right for
Postoperative BleedingSkin Cancer Face
Vanderbilt University Medical Center 100
Next Page